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OBJECTIVE—Diabetes is a major cause of functional decline among older adults, but the role
of glycemic control remains unclear. This article assesses whether better glycemic control is
associated with better maintenance of lower-extremity function over time in older adults with
diabetes.
RESEARCH DESIGN AND METHODS—Participants (n = 119) in the San Antonio
Longitudinal Study of Aging, ages 71–85, who met American Diabetes Association diabetes
criteria were followed over a 36-month period. Seven measures of A1C (HbA1c) were obtained
at 6-month intervals; three measures of lower-extremity function were obtained at 18-month
intervals using the Short Physical Performance Battery (SPPB). A two-step analytic approach was
used, ﬁrst, to identify distinct glycemic control classes using latent growth mixture modeling
and, second, to examine trajectories of lower-extremity function based on these classes using
path analysis.
RESULTS—Two glycemic control classes were identiﬁed: a poorer control class with higher
means (all .7%) and higher within-subject variability in HbA1c and a better control class with
lower means (all ,7%) and lower within-subject variability. The short-term and long-term
maintenance of lower-extremity function, assessed by the association between the ﬁrst and
second SPPB measures and the ﬁrst and third SPPB measures, were both greater in the better
control class than in the poorer control class.
CONCLUSIONS—Among older adults with diabetes, better glycemic control may improve
both short-term and long-term maintenance of lower-extremity function.
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D
i a b e t e si sam a j o rp u b l i ch e a l t h
problem in U.S. older adults, with
prevalence of diagnosed and undi-
agnosed diabetes exceeding 17% in both
sexes (1).Moreover, ithas been estimated
that approximately 25% of older adults
(.1.2 million) with diabetes are unable
to walk one-fourth mile, climb 10 stairs,
ordo houseworkand approximately50%
(.2.5million) have difﬁculty performing
these tasks (2). Among women, yearly in-
cidence of any functional disability
among those with diabetes has been esti-
m a t e da t9 . 8 %c o m p a r e dw i t ha ni n c i -
dence of 4.8% among those without
diabetes(3).AmongolderMexicanAmer-
icans of both sexes, the rate of decline in
functional status has been reported to be
more rapid among those with diabetes
versus those without diabetes (4). Cross-
sectionalanalysesfromtheHealth,Aging,
and Body Composition Study (Health
ABC) suggested that A1C (HbA1c , vs.
$ 7%) may explain the association of
diabetes with subclinical functional limi-
tation (5). In addition, longitudinal anal-
yses of the association of diabetes with
mobility- and activity of daily living
(ADL) disability in a subsample of partic-
ipants in the Women’s Health and Aging
Study(WHAS)suggestedthatadjustment
for HbA1c reduces the excess diabetes-as-
sociatedriskofsuchdisabilityby36–65%
(6). However, no longitudinal analyses
have examined the role of glycemic con-
trol in physical functional decline in both
sexes or in cohorts that include large pro-
portions of Mexican Americans as well as
European Americans.
The current study uses longitudinal
data from the San Antonio Longitudinal
Study of Aging (SALSA), a community-
based study of disablement in a biethnic
cohort of Mexican Americans and Euro-
pean Americans toexamine whether better
glycemic control improves the mainte-
nance oflower-extremity physicalfunction
over a 36-month period among partici-
pants with diabetes.
RESEARCH DESIGN AND
METHODS
Sample
SubjectswereparticipantsintheSALSA,a
community-based study of the disable-
ment process in Mexican American (MA)
and European American (EA) older
adults, composed of a baseline examina-
tion (1992–1996) and follow-up study
(2000–2005), an average of 6.9 years
later. The oldest members (age 65+ years)
of the San Antonio Heart Study (SAHS)
cohort, a community-based study of eth-
nic differences in risk factors for diabetes
and cardiovascular disease, were recruited
to participate in the SALSA baseline study.
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ORIGINAL ARTICLEIn the SAHS, subjects were randomly sam-
pled from low-, middle-, and high-income
neighborhoodsinordertoprovideacohort
withcomparable numbersofMAs and EAs
and to maximize sociocultural variation
among MAs in the study; details of the
SAHSstudydesign,samplingapproach,re-
cruitment, and ﬁeld procedures have been
described previously (7). The SALSA base-
lineresponseratewas70.5%(749of1,062
eligible candidates); there was no evidence
of major response bias to the SAHS survey
among people who later became SALSA
age-eligible and no evidence of major attri-
tion bias between the initial SAHS survey
and the SALSA survey.
The SALSA follow-up study included
three visits 18 months apart for all par-
ticipants. Among those diagnosed with
diabetes, HbA1c was also assessed at
6-month intervals. The response rates
among baseline survivors were: follow-
up 1, 79.1% (474 of 599); follow-up 2,
73.4% (413 of 563); and follow-up 3,
71.0%(375of528).Therewasnoevidence
of major response bias over the follow-up
interval.Thesampleforthecurrentstudyis
thesubsetof119subjectswhoparticipated
in the follow-up study and had diagnosed
diabetes at the time that study began.
The SALSA baseline and follow-up
studies were approved by the Institu-
tional Review Board of the University of
TexasHealthScienceCenteratSanAntonio,
and all subjects gave informed consent.
Measures
Assessments were conducted by trained,
bilingual staff using standardized proto-
cols. Diabetes was classiﬁed based on
American Diabetes Association criteria
(8) as a fasting plasma glucose $126
mg/dL or current diabetic medication
use. Lower-extremity physical functional
limitation was measured with the Short
Physical Performance Battery (SPPB), a
well-established, validated measure con-
structedfrom8-footwalkingtime,repeated
chairstands,andbalancescores(9).Higher
scores indicate better performance and less
functional limitation. Angina was assessed
with the Rose questionnaire (10); stroke
was assessed as self-reported doctor-
diagnosed disease. Hypertension was as-
sessedusingguidelinesinthesixthreport
oftheJointNationalCommitteeonPreven-
tion, Detection, Evaluation,and Treatment
of High Blood Pressure (11) as a systolic
pressure $140 mmHg or a diastolic pres-
sure $90 mmHg or current antihyperten-
sive medication. Pulmonary function was
assessed as forced expiratory volume at 1 s
(FEV1) measured with the Welch-Allyn
Pneumocheck (Skaneateles, NY) (12).
BMI was measured as weight in kilograms
divided by height in meters squared. Eth-
nic background was classiﬁed using a
standardized, validated algorithm (13).
Education (years of formal schooling)
was ascertained by self-report.
Ankle-brachial pressure indexes
(ABIs) were calculated as the ratio of the
higher systolic pressure of the dorsalis
pedis or posterior tibial for each leg over
the mean of the right and left brachial
systolicbloodpressure.Peripheralarterial
disease(PAD)wasdeﬁnedasanABI,0.9
in either leg and was considered absent if
an ABI of 0.9–1.3 was present in both legs.
AnABI.1.3wasdeﬁnedashighandnon-
compressible. Based on evidence suggest-
ing equivalence of low and high ABIs (14),
the latter were considered as having PAD.
Peripheral nerve dysfunction (PND)
w a sm e a s u r e da sv i b r a t i o np e r c e p t i o n
threshold(VPT)(15)usingaHorwellNeu-
rothesiometerwiththeprobebalancedver-
tically on the pulp of the great toe. The
neurothesiometer measures sensitivity in
detecting sensory vibratory stimuli. Scores
(0–50)werethemeanofthreereadingswith
scores for the right foot used in the analy-
ses. Higher scores indicate worse PND.
Analysis
We used a two-step analytic approach,
which incorporated the latent growth
mixture modeling (LGMM) technique
into a path analysis. The ﬁrst step was to
use LGMM (16) to identify statistically
distinct glycemic control classes and to
quantify subjects’ glycemic control status
based on seven repeated measures of
HbA1c.Asubject’sglycemiccontrolstatus
was assessed by the likelihood of being in
each glycemic control class or, speciﬁ-
cally, by the propensity score (or poste-
rior probability) of being in each class
given the subject’s observed HbA1c mea-
sures, covariates, and the LGMM analysis
result. In the second step, these propen-
sity scores were incorporated as weights
(reﬂectingtheprobabilityofbeingineach
glycemic control class) in the path mod-
eling of SPPB scores to assess the class-
speciﬁc relationship among SPPB scores.
Toelaboratefurther,LGMMwasused
in step 1 to quantify subjects’ glycemic
control status (or class) since it is an ex-
ploratory multivariate statistical tech-
nique, analogous to cluster analysis for
longitudinal data, which permits the
identiﬁcation of distinct latent classes
in a study while adjusting for covariates.
For the current study, the unobserved la-
tentclassesweredeterminedbasedonthe
similarity of the patterns of the seven re-
peatedmeasuresofHbA1ccollectedovera
3 6 - m o n t hp e r i o da t6 - m o n t hi n t e r v a l s .
The patterns of HbA1c measures were
b a s e do nb o t ht h em e a n sa n dt h e
within-subject variability of these mea-
sures over time. LGMM analyses require
speciﬁcationofthenumberoflatentclasses
and the pattern of repeated measures for
each class. Covariates included in the
LGMM analysis were age, sex, ethnicity,
education, BMI, and hypertension. To de-
termine the best ﬁt LGMM to the data, we
used two goodness-of-ﬁt indexes, Akaike
information criterion, and Bayesian infor-
mation criterion, as well as residual diag-
nostics (17). Each subject’sg l y c e m i c
control class (HbA1c trajectories) identi-
ﬁed by LGMM analyses was characterized
in terms of the subject’s propensity score
(or the likelihood) for membership in
each glycemic control class. For example,
inamodelwithtwolatentclasses,propen-
sity scores of 0.9 and 0.1 for a given sub-
ject suggest that he or she is likely to
belong to the ﬁrst class with a probability
of0.9(90%)andtothesecondclasswitha
probability of 0.1 (10%). In step 2, these
propensity scores were then used as
weights in path analyses of SPPB scores
during the three follow-ups. More specif-
ically, this mixture path modeling was
used to assess the class-speciﬁc effect of
lower-extremity functioning (measured
by SPPB) in follow-up 1 on functioning
in follow-ups 2 and 3 while adjusting for
covariate effects and the class-speciﬁc ef-
fect of SPPB in follow-up 2 on functioning
in follow-up 3. Covariates included in the
path analyses were age, education, ethnic-
ity, BMI, angina, stroke, and pulmonary
function (FEV1) measured at follow-up 1.
The research question (whether the
impact of baseline functional status on
subsequent functioning over 18- and 36-
month periods can be improved by better
glycemic control) was addressed by com-
paring the adjusted correlations between
SPPB at follow-up 1 and at follow-up 2 as
well as between SPPB at follow-up 1 and
at follow-up 3 across the identiﬁed glyce-
mic control classes. Mplus software (18)
wasusedtoobtainmodelestimates.Inthe
step1 analysis,subjectswith missing data
on the covariates or all HbA1c values (N =
2) were excluded from the analyses; in
step 2, subjects with missing values on
the covariates (N = 6) or all SPPB values
(N = 4) were excluded. The total number
of subjects included in the step 2 analysis
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Wang and Hazudawas 107. Partial missing data on HbA1c
and SPPB were addressed utilizing the
full-information maximum likelihood
(FIML) method. FIML uses the entire set
of the observed data matrix to estimate
parameters. In contrast with list-wise de-
letion or multiple imputations, FIML
yields unbiased parameter estimates
whendataaremissingatrandomandpre-
serves the overall power and efﬁciency of
the analysis (17).
To further characterize the latent
classes identiﬁed in step 1, a pseudoclass
estimationtechnique(17)wasusedtocal-
culate for each glycemic control class 1)
the proportion of subjects who were
newly diagnosed with diabetes, 2)t h e
proportion of subjects who had PAD,
and 3) the means and standard deviations
of VPT and diabetes duration.
RESULTS—Sample characteristics are
d e s c r i b e di nT a b l e1 .A ss h o w ni nF i g .1 ,
two latent classes of HbA1c trajectories
were identiﬁed: one with higher means
and greater within-subject variability in
HbA1cover time (called the poorer glyce-
mic control class, 55.3% of the sample)
and the other class (called the better gly-
cemic controlclass,44.7% of thesample)
with lower means and less within-subject
variability in HbA1c over time. These two
classes are statistically distinct as well as
clinically meaningful because the means
of the seven repeated measures of HbA1c
in the poorer control class were all greater
than 7%, whereas the corresponding
means in the better control class were all
below 7%, the clinical threshold com-
monly used to designate acceptable glyce-
mic control. Membership in the better
control class versus the poorer control
class was associated with older age and
higher education level (the odds ratios
for 1 additional year of age and education
were 6.88 and 1.13, respectively). Al-
though the proportion of those newly di-
a g n o s e dw i t hd i a b e t e si nt h eb e t t e r
glycemic control class compared with the
poorercontrolclasswas30.4% vs.17.1%,
average years of diabetes duration in the
better control class was only slightly less
than that in the poorer control class
(11.4 6 11.5 vs. 12.8 6 11.5). Although
the proportion of subjects with PAD was
lower in the better control class than in
the poorer control class (47.8% vs.
51.7%), the average VPT was somewhat
higher (19.4 6 11.8 vs. 17.8 6 10.6, re-
spectively).
The associations of SPPB at follow-up
1 with SPPB at follow-ups 2 and 3 are
shown in Table 2. The covariate-adjusted
association between SPPB scores mea-
sured at follow-ups 1 and 2 was greater
in the better control class than that in the
poorer control class (adjusted correlation
0.86 and 0.68, respectively), suggesting
that the short-term impact of baseline
SPPB on SPPB scores 18 months after
baseline was also greater in the better gly-
cemic control class than that in the
poorer control class. In addition, the mag-
nitude of the positive association between
SPPB at follow-up 1 and follow-up 3, ad-
justed for baseline covariates and SPPB at
Table 1—Sample characteristics
Variable* % Mean (SD) Range
Age (years) 76.3 (3.4) 7–85
Female (%) 54.6
Mexican American (%) 71.4
Education (years) 10.2 (4.9) 0–20
Household income (category) 12.8 (4.0) 2–19
Diabetes duration (years) 12.5 (11.2) 0–51
Newly diagnosed for diabetes 22.7
PVD 50.4
VPT 18.5 (11.2) 0–50
BMI (kg/m
2) 29.7 (5.2) 18.4–47.7
Forced expiratory volume at 1 s (liters) 1.6 (0.6) 0.4–3.7
Angina (%) 15.4
Stroke (%) 18.6
Hypertension (%) 73.1
SPPB 7.6 (3.4) 0–12
Walking times 2.8 (1.2) 0–4
Balance 2.5 (1.4) 0–4
Chair stands 2.0 (1.3) 0–4
*A household income category of 12.8 equals ;$23,800 annually; angina and stroke were assessed by self-
report;presence of hypertensionwasassessedasasystolic pressure $140mmHg or adiastolic pressure $90
or current antihypertensive medication.
Figure 1—Mean trajectories of two latent classes estimated by LGMM of HbA1c. Solid line
connectsthemeansofHbA1c;brokenlinesconnectthe95%conﬁdenceboundsoftheHbA1cmeans.
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Glycemic control and lower-extremity functionfollow-up 2, was greater in the better gly-
cemic control class compared with that
in the poorer control class, suggesting
that the long-term impact of baseline
SPPB on SPPB scores 36 months later
was greater in the better glycemic control
class compared with the poorer control
class (adjusted correlation 0.62 and 0.42,
respectively). The differential temporal
associations (follow-up 1 to follow-up 2
and follow-up 1 to follow-up 3) in the
totalSPPBscore between glycemic control
classes held true for the SPPB component
scoreswiththeexceptionofchairstandsat
36 months.
CONCLUSIONS—Using a two-step
analysis of 119 individuals with diabetes
in the SALSA, we identiﬁed two distinct
glycemic control trajectory classes based
on seven repeated measures of HbA1c 6
months apart: a poorer control class with
higher means (all .7%) and greater
within-subject variability in HbA1c and a
better control class with lower means (all
,7%) and lower within-subject variabil-
ity. At study initiation, the mean SPPB
score in the better glycemic control class
was 8.3 compared with 7.1 in the poorer
glycemic control class, indicating that
those with better glycemic control at
study initiation had a meaningful, sub-
stantially better level of lower-extremity
function than did those with poorer gly-
cemic control (19). We showed that both
short-term(18month)andlong-term(36
month) maintenance of lower-extremity
function (measured by the SPPB) were
greaterinthebetterglycemiccontrolclass
than in the poorer glycemic control class.
Maintenance of lower-extremity function
as assessed by the SPPB is particularly
important because poor performance on
this measure has been associated with in-
creased incident disability, nursing home
placement, and mortality (9).
Prior studies that examined the re-
lationship between HbA1c and physical
function among older adults with diabe-
tes (5,6) suggested that the relationship
between diabetes and functional decline
maybemediatedbyglycemiccontrol.These
studies,however,had severallimitations.
The Health ABC study included only
well-functioning individuals in a re-
stricted age range (70–79 years old) and
examined this association cross-sectionally
(5). Although the WHAS examined lon-
gitudinally whether the association of di-
abetes with onset of mobility- and ADL
disability was mediated by HbA1c,t h e
study sample included only women who
were $65 years old and were among the
33% most disabled women living in the
Baltimore community (6). Neither study
included Hispanics. The Sacramento Area
Latino Study on Aging (4) reported lower
baseline functional status and more rapid
functional decline among older Mexican
Americans with diabetes compared with
those without diabetes, but data on HbA1c
levels were not collected. None of these
prior studies examined the potential
moderating effect of glycemic control on
functional decline in the presence of dia-
betes. Our study extends these previous
investigations by examining the potential
moderatingeffect ofglycemic controlover
time on the association between diabetes
and functional decline in a cohort com-
prising both sex groups and large propor-
tions of Mexican Americans as well as
European Americans. Our results suggest
thatthelevelofglycemiccontrolovertime
moderates both short-term and long-term
maintenance of physical function in older
adults with diabetes. More speciﬁcally,
we found that the impact of initial SPPB
scores on SPPB scores 18 and 36 months
later was greater in those with better gly-
cemic control compared with those with
poor glycemic control, suggesting that
the maintenance of physical function
over time is improved by better glycemic
control.
The mechanism by which better gly-
cemic control improves or sustains phys-
ical function over time among people
with diabetes is not yet clear. One poten-
tial mechanism, however, is by reducing
or delaying the development of diabetes
complications such as PAD and PND.
This posited mechanism is consistent
with theresults ofseveral signiﬁcant prior
studies. The UKPDS long-term random-
ized controlled trial in type 2 diabetes
demonstrated that better glycemic con-
trol resulted in reduced risk of both
macrovascular and microvascular com-
plications (20). Furthermore, the associa-
tion of PAD and nerve conduction
velocity with lower-extremity function
has been documented in a population-
based study of older adults (21). With re-
gard to the maintenance of physical
function, a potential mechanism for the
effect of good glycemic control may be
the so-called legacy effect as shown in
the UKPDS (22); that is, for patients
with type 2 diabetes, if the glycemic con-
trol goal is appropriately tailored to pa-
tients’ conditions at an early stage of the
disease, then it could result in a long-
lasting effect on the development of com-
plications. However, the role of tailored
glucose control in the disablement pro-
cess (23) has received little attention in
the literature.
Inthecurrentstudytheproportionof
subjects with newly diagnosed diabetes
was almost twice as high in the better
glycemic control class than in the poorer
control class, suggesting that shorter du-
rationofdiabetesintheformergroupmay
have been associated with a lower prev-
alence of complications such as PAD and
PND, which, in turn, accounted for the
better maintenance of lower-extremity
function in this group. However, the
average duration of diabetes in the better
controlgroupwasonly1.4years lessthan
that in the poorer control group. In
addition, whereas prevalence of PAD
was lower in the better control group,
VPT was somewhat higher. Thus our data
offerasomewhatmixedpicturewithregard
Table 2—Covariate-adjusted correlation among SPPB scores by latent glycemic control class
Betterglycemiccontrol(44.7%) Poorerglycemiccontrol(55.3%)
Estimate SE Z value Estimate SE Z value
Total SPPB
Follow-up 1→follow-up 2 0.86 0.2 5.54** 0.68 0.1 5.09**
Follow-up 1→follow-up 3 0.62 0.2 3.74* 0.42 0.2 2.32*
Walking time
Follow-up 1→follow-up 2 0.94 0.2 4.85** 0.50 0.2 2.84**
Follow-up 1→follow-up 3 0.87 0.2 4.43** 0.50 0.2 2.75**
Balance
Follow-up 1→follow-up 2 0.52 0.2 3.23** 0.37 0.1 2.54*
Follow-up 1→follow-up 3 0.28 0.2 1.34 0.17 0.2 1.01
Chair stands
Follow-up 1→follow-up 2 0.64 0.1 6.84** 0.45 0.2 2.85**
Follow-up 1→follow-up 3 0.39 0.2 2.02* 0.49 0.1 4.3**
*For effects with 0.01 # P values , 0.05. **For effects with P values , 0.01.
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Wang and Hazudato the potential role of differences in di-
abetesdurationandcomplicationsbetween
thetwoglycemiccontrolclassesinexplain-
ing the moderating effect of glycemic con-
trol on lower-extremity functioning.
Our study included subjects with a
wide range of glycemic control over time
and found a substantial association be-
tween HbA1c and lower-extremity func-
tional limitation. It may be that some
studies reporting a weak or absent associ-
ation of HbA1c with lower-extremity
complications have been conducted in
cohorts composed of subjects with such
long-standing, poorly controlled diabetes
that the likelihood of carrying out mean-
ingfulanalysesoftheassociationofHbA1c
with the outcomes of interest is greatly
diminished (e.g., studies of wound healing
in people with diabetic foot ulcers) (24).
Based on the current ﬁndings, we
hypothesize that the initial effect of an
intervention designed to improve lower-
extremity function in older adults with
diabetes (e.g., lower-extremity strength
training) will be sustained for longer peri-
ods of time in those with better glycemic
control than in those with poorer control.
One possible strategy for testing this hy-
pothesis is to conduct a randomized con-
trolled trial with the intervention and
control arms balanced within clinically
distinct baseline HbA1c stratum (identiﬁed
based on repeated measures of HbA1c
over a prior time period). Such a study
may not only demonstrate better mainte-
nance of physical function among subjects
with better glycemic control over a 36-
month period but also provide the basis
for examining whether there might be an
even longer beneﬁt resulting from a legacy
effect of better glycemic control. If the re-
sults of such a study were positive, they
would provide evidence of an additional
beneﬁt of good glycemic control, namely,
better maintenance of lower-extremity
physical function. Results of the current
study already suggest that, whether some-
one with diabetes takes part in activities
speciﬁcally designed to increase the level
oflower-extremityfunction,goodglycemic
control can delay or reduce subsequent
functional decline.
Whilethecurrentstudyislimitedtoa
small number of subjects, the seven re-
peated measures of HbA1c and three re-
peated measures of SPPB collected over a
3 6 - m o n t hp e r i o dp r o v i d e ds u f ﬁcient
power to demonstrate that glycemic con-
trol may moderate lower-extremity func-
tional decline among older adults with
diabetes. Generalizability of the results
may be limited by the single geographic
location of the study, inclusion of only
Mexican American and European Ameri-
can participants, and the age range (71–
85 years old) of the sample. Nonetheless,
the study provides promising evidence to
support the added beneﬁt of good glyce-
mic control on both short-term and long-
term maintenance of physical function in
the presence of diabetes.
Acknowledgments—This study was sup-
ported by National Institute on Aging (NIA)
Grant 1-R01-AG10444 (SALSA), NIA Grant
1-R01-AG16518 (Disablement in an Aging,
Bi-ethnic Cohort), National Institute of Di-
abetes and Digestive and Kidney Diseases
Grant1-K25DK075092,andNationalCenter
for Research Resources Grant M01-RR01346
(FredrickC.BartterGeneralClinicalResearch
Center). This material is the result of work
supported with resources and the use of fa-
cilities at the Audie Murphy VA Medical
Center, San Antonio, TX.
No potential conﬂicts of interest relevant to
this article were reported.
C.P.W. wrote the article, performed data
analyses, and interpreted results. H.P.H. con-
tributed to all aspects of the article as senior
author.
References
1. Harris MI, Flegal KM, Cowie CC, et al.
Prevalence of diabetes, impaired fasting
glucose, and impaired glucose tolerance
in U.S. adults. The Third National Health
and Nutrition Examination Survey, 1988–
1994. Diabetes Care 1998;21:518–524
2. Gregg EW, Beckles GL, Williamson DF,
et al. Diabetes and physical disability
among older U.S. adults. Diabetes Care
2000;23:1272–1277
3. Gregg EW, Mangione CM, Cauley JA,
et al; Study of Osteoporotic Fractures
Research Group. Diabetes and incidence
of functional disability in older women.
Diabetes Care 2002;25:61–67
4. Wu JH, Haan MN, Liang JL, Ghosh D,
Gonzalez HM, Herman WH. Diabetes as a
predictor of change in functional status
among older Mexican Americans: A pop-
ulation-based cohort study.Diabetes Care
2003;26:314–319
5. De Rekeneire N, Resnick HE, Schwartz
AV, et al; Health, Aging, and Body Com-
position study. Diabetes is associated
with subclinical functional limitation
in nondisabled older individuals: The
Health, Aging, and Body Composition
study. Diabetes Care 2003;26:3257–3263
6. Volpato S, Ferrucci L, Blaum C, et al.
Progression of lower-extremity disability in
older women with diabetes: The Women’s
Health and Aging Study. Diabetes Care
2003;26:70–75
7. Hazuda HP, Haffner SM, Stern MP, Eiﬂer
CW. Effects of acculturation and socio-
economic status on obesity and diabetes
in Mexican Americans. The San Antonio
Heart Study. Am J Epidemiol 1988;128:
1289–1301
8. Expert Committee on the Diagnosis and
Classiﬁcation of Diabetes Mellitus. Report
of the expert committee on the diagnosis
and classiﬁcation of diabetes mellitus.
Diabetes Care 2003;26(Suppl. 1):S5–S20
9. Guralnik JM, Simonsick EM, Ferrucci L,
etal.Ashortphysicalperformancebattery
assessing lower-extremity function. As-
sociation with self-reported disability and
prediction of mortality and nursing home
admission.JGerontol1994;49:M85–M94
10. Rose GA, Blackburn H. Cardiovascular Sur-
vey Methods. Geneva, Switzerland, World
Health Organization, 1968
11. National Committee on Prevention, De-
tection Evaluation and Treatment of High
Blood Pressure. The sixth report of the
Joint National Committee on prevention,
detection, evaluation, and treatment of
high blood pressure. Arch Intern Med
1997;157:2413–2446
12. Barkley B, Lichtenstein MJ, Garza C,
Hazuda HP. Clinical validation of the
Welch-Allyn Pneumocheck hand-held spi-
rometer. Am J Med Sci 1994;308:357–359
13. Hazuda HP, Comeaux PJ, Stern MP,
Haffner SM, Eiﬂer CW, Rosenthal M. A
comparison of three indicators for iden-
tifying Mexican Americans in epidemio-
logic research. Methodological ﬁndings
from the San Antonio Heart Study. Am J
Epidemiol 1986;123:96–112
14. ResnickHE,LindsayRS, McDermottMM,
et al. Relationship of high and low ankle
brachial index to all-cause and cardiovas-
cular disease mortality: the Strong Heart
Study. Circulation 2004;109:733–739
15. Resnick HE, Vinik AI, Schwartz AV, et al.
Independent effects of peripheral nerve
dysfunction on lower-extremity physical
function in old age: The Women’sH e a l t h
and Aging Study. Diabetes Care 2000;23:
1642–1647
16. Muthen B. Beyond SEM: General latent
variable modeling. Behaviormetrika 2002;
29:81–117
17. Wang CP, Brown CH, Bandeen-Roche K.
Residual diagnostics for growth mixture
models: Examining the impact of a pre-
ventive intervention on multiple trajec-
tories of aggressive behavior. J Am Stat
Assoc 2005;100:1054–1076
18. Muthen LK, Muthen BO. Mplus user’s
guide. Muthen and Muthen. Los Angeles,
CA, p. 1999–2006.
19. Perera S, Mody SH, Woodman RC,
Studenski SA. Meaningful change and
responsiveness in common physical per-
formance measures in older adults. J Am
Geriatr Soc 2006;54:743–749
20. Stratton IM, Adler AI, Neil HAW, et al. As-
sociation of glycaemia with macrovascular
272 DIABETES CARE, VOLUME 34, FEBRUARY 2011 care.diabetesjournals.org
Glycemic control and lower-extremity functionand microvascular complications of type 2
diabetes (UKPDS 35): prospective obser-
vational study. BMJ 2000;321:405–412
21. McDermott MM, Guralnik JM, Albay M,
Bandinelli S, Miniati B, Ferrucci L. Im-
pairments of musclesand nervesassociated
with peripheral arterial disease and their
relationship with lower extremity function-
ing:theInCHIANTIStudy.JAmGeriatrSoc
2004;52:405–410
22. HolmanRR,PaulSK,BethelMA,Matthews
DR, Neil HAW. 10-year follow-up of in-
tensive glucose control in type 2 diabetes.
N Engl J Med 2008;359:1577–1589
23. Verbrugge LM,JetteAM.The disablement
process. Soc Sci Med 1994;38:1–14
24. Margolis DJ, Kantor J, Santanna J, Strom
BL, Berlin JA. Risk factors for delayed
healing of neuropathic diabetic foot ul-
cers: a pooled analysis. Arch Dermatol
2000;136:1531–1535
care.diabetesjournals.org DIABETES CARE, VOLUME 34, FEBRUARY 2011 273
Wang and Hazuda